Evidence map›Paper›PMID 41075091›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Molegro Data Modeller for Machine Learning.

Amauri Duarte da Silva, Nelson José Freitas da Silveira, Patrícia Rufino Oliveira, Walter Filgueira de Azevedo

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Amauri Duarte da SilvaGraduate Program in Information Technologies and Health Management, Federal University of Health Sciences of Porto Alegre, Porto Alegre, RS, Brazil.
Nelson José Freitas da SilveiraLaboratory of Molecular Modeling and Computer Simulation, Federal University of Alfenas, Alfenas, Brazil.
Patrícia Rufino OliveiraSchool of Arts, Sciences and Humanities, University of São Paulo, São Paulo, SP, Brazil.
Walter Filgueira de AzevedoDepartment of Physics, Institute of Exact Sciences, Federal University of Alfenas, Alfenas, MG, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Machine learning methods have great potential to build models to address protein-ligand interactions obtained through docking simulations. Molegro Data Modeller (MDM) has an intuitive interface with Molegro Virtual Docker (MVD), which allows us to integrate docking results and machine learning. Here, we present a tutorial on how to build a regression model using a support vector machine to predict the inhibition of cyclin-dependent kinase 2 with MDM. Our model relies on docked poses of CDK2 inhibitors obtained with MVD and employs the support vector machine implemented in the MDM program. We focus on ligands for which binding affinity data is available at the BindingDB and the structure of a CDK2-Cyclin complex determined using crystallography. Our approach explores the concept of scoring function space to build targeted models. We take descriptors, energy terms, and scoring functions determined with MVD to build our machine learning model. All CDK2 datasets and Jupyter Notebooks discussed in this work are available at GitHub: https://github.com/azevedolab/docking#readme .

Indexed as

Computational BiologyCyclin-Dependent Kinase 2Machine LearningMolecular Docking SimulationProtein Kinase InhibitorsSoftwareHumansLigandsProtein BindingSupport Vector MachineCDK2 protein, humanCyclin-Dependent Kinase 2LigandsProtein Kinase InhibitorsCyclin-dependent kinase 2Docking screenDrug discoveryMolegro Data ModellerScoring function spaceSupport vector machine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.